Gene Query: UBE2D4

Dataset Description Geneva Score
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 22.73
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 19.98
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 17.98
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 14.64
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 13.87
Argonaute proteins couple chromatin silencing to alternative splicing 11.25
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 11.25
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 10.29
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 10.24
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 9.79
Gene expression changes after LOC550643 silencing 9.24
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 8.75
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 8.75
HNF1A deficiency impairs β-cell fate, granule maturation and function 8.42
An integrative analysis of non-coding regulatory DNA variations associated with autism 8.29
Sensing self and nonself circular RNAs 8.29
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 7.81
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 7.44
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 7.44
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 7.4
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 7.21
Differentiation enhances Zika virus infection in neuronal brain cells 7.21
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 7.18
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 7.18
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 7.07
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 6.99
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 6.99
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 6.64
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 6.17
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 6.17
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 6.09
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 5.95
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 5.93
single cell RNA-seq from GM12878 (ENCSR673UIY) 5.59
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 5.55
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 5.55
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 5.39
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 5.35
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 5.27
Transcriptome analysis of kidney organoids 5.18
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 5.09
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 4.97
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 4.65
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 4.41
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 4.38
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 4.38
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 4.34
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 4.29
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 4.22
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 4.16
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 4.16
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 4.14
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 4.05
Characterization of parental and rociletinib-resistant derived H1975 cell lines 4.05
Role of microRNAs in the interaction between Salmonella and the host cell 3.97
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 3.95
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 3.9
Transcriptome of human white and brown adipose tissue biopsies 3.89
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 3.85
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 3.81
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 3.78
Altering cancer transcriptomes using epigenomic inhibitors 3.77
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 3.77
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 3.76
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 3.74
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 3.64
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 3.55
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 3.53
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 3.52
Transcriptomic analyssis following EHMT1/2 inhibition 3.47
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 3.46
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 3.45
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 3.34
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 3.32
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 3.32
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 3.25
RNA polymerase in pre-B-ALL cell lines 3.22
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 3.2
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 3.2
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 3.18
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 3.15
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 3.14
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 3.11
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 3.09
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 3.09
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 3.09
Mutational landscape of splicing genes and functional consequences across 33 cancer types 3.02
LNCaP treated with iBET 2.95
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 2.92
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 2.86
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 2.86
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 2.86
Expression by CD133+ cells isolated from the adult human exocrine pancreas 2.79
Cleavage Factor Im as a key regulator of 3’ UTR length 2.78
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 2.78
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 2.78
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 2.78
Regulatory network controlling tumor-promoting inflammation in human cancers 2.75
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 2.75
MicroRNA-125a-5p overexpression in human macrophages 2.72
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 2.71
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 2.69
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 2.62
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 2.62
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 2.62
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 2.61
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.6
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 2.55
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 2.55
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 2.54
Integrating single-cell transcriptomic data across different conditions, technologies, and species 2.52
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 2.46
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 2.45
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 2.44
2.42
Loss of CREBBP results in gene expression repression in lymphoma cells 2.42
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 2.42
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 2.39
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 2.39
Tumor exosome integrins determine organotropic metastasis 2.36
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.34
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.34
DART-seq: an antibody-free method for global m6A detection 2.34
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 2.33
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 2.33
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 2.33
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 2.33
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.33
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 2.32
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.28
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 2.26
A single-cell transcriptome atlas of the human pancreas 2.26
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 2.26
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.25
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 2.22
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 2.22
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 2.21
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.2
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 2.19
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 2.19
Generating Patterned Kidney Organoids for Studying Development and Diseases 2.18
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 2.16
Identification of renal resident macrophages across species 2.14
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 2.13
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 2.13
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 2.12
Gene expression in PANC1 cells treated with Rakicidin 2.12
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 2.12
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 2.12
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 2.12
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 2.08
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 2.04
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 2.04
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 2.04
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 2.03
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 2.02
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 2.02
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 2.01
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 1.98
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 1.98
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 1.98
Glioblastoma stem cells infected by ZIKA virus 1.97
RNA-seq analysis of AML cells in response to ASLAN003 1.97
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 1.95
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.93
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.93
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 1.93
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 1.91
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.9
LINE-2 transposable elements are a source of functional human microRNAs and target sites 1.9
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 1.89
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 1.89
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.86
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.86
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 1.85
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 1.82
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 1.81
Neonatal and adult human testis defined at the single-cell level 1.81
Transcriptome profiling of Normal and Cancerous Prostate Cells 1.8
Reassessment of Exosome Composition 1.79
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 1.79
EP400 is required for Max and MCPyV mediated gene activation 1.78
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.76
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 1.75
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 1.73
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.72
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 1.71
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 1.7
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 1.68
PTHrP overexpression in MCF7 cells 1.68
CDK4/6 inhibitor resistance in prostate cancer 1.67
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 1.67
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.66
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 1.65
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 1.65
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.63
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 1.63
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 1.59
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 1.59
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 1.59
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 1.59
Transcriptional landscape changes during human embryonic stem cell derivation 1.58
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 1.58
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 1.58
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 1.58
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 1.57
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.55
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 1.55
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 1.54
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 1.53
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 1.53
High-throughput sequencing of PROMPT-enriched samples. 1.53
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 1.53
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 1.52
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 1.51
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 1.51
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 1.51
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 1.5
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 1.5
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 1.49
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.49
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 1.49
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 1.48
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 1.48
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 1.46
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 1.46
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 1.46
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 1.45
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 1.44
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 1.41
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 1.41
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 1.41
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 1.4
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 1.4
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 1.4
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 1.4
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 1.4
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 1.4
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.39
mRNA recovered upon RNF219 IP. [RNA-IP] 1.37
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.37
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.37
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 1.36
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 1.36
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 1.35
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 1.34
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 1.33
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 1.33
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 1.33
Genetic-to-epigenetic Therapy for Pancreatic Cancer 1.33
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 1.32
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 1.32
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.31
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 1.31
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 1.31
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 1.3
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 1.3
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 1.3
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 1.29
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 1.29
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 1.28
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 1.28
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 1.25
MYC dependent mRNA translation shapes gene expression and cell biology 1.23
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.23
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 1.22
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.22
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.22
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.21
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.21
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 1.21
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.21
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.19
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 1.19
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 1.19
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 1.18
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 1.18
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 1.18
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.17
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 1.17
Studying the selectivity of a small molecule Synucleozid on transcriptome 1.16
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.16
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.16
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 1.16
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.16
Single-Cell Genotyping of Transcriptomes 1.16
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 1.15
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 1.15
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 1.15
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 1.14
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 1.12
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 1.12
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 1.11
RNA-seq of IL-4 stimulated human keratinocytes 1.11
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 1.09
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.09
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 1.08
RNA-Seq with and without RNase treatment in PCa cell lines 1.08
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.07
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 1.06
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 1.05
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 1.04
Modeling Human Cancer-induced Cachexia (Human) 1.04
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.03
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 1.02
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 1.0
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.0
Induced DNA demethylation, genome instability and transcription 1.0
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 0.99
Tyrosine Kinase Inhibitor Cardiotoxicity 0.99
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.99
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 0.97
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.96
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  0.94
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 0.94
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 0.94
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 0.93
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 0.93
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.93
Discovering human diabetes-risk gene function with genetics and physiological assays 0.92
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 0.89
Effect of CHKA knockdown on C4-2 cell transcriptome 0.89
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 0.88
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 0.87
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.86
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.86
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.86
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.84
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 0.84
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 0.84
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 0.83
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.81
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.81
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 0.81
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 0.81
TAF1 is critical for AE driven leukemogenesis 0.81
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 0.81
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.8
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.79
Paxillin regulates genomic networks in prostate cancer [C4-2] 0.79
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 0.79
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 0.79
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 0.79
High-resolution comparative analysis of great ape genomes 0.79
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 0.79
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.78
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.77
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 0.77
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 0.76
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 0.74
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 0.73
The effect of insulin on mRNA transcription of human pluripotent stem cells 0.73
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.72
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.72
A single cell reference map for human blood and tissue T cell activation 0.72
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 0.72
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 0.7
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.7
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.68
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 0.68
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 0.68
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 0.67
mRNA expression in human DAOY cells 0.67
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.67
Identification of expressed and conserved human non-coding RNAs 0.67
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 0.66
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.65
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.65
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.64
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 0.64
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.64
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 0.63
Entrectinib Resistance in a Neuroblastoma Xenograft Model 0.62
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 0.61
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.61
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.61
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 0.6
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.6
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 0.59
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 0.59
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.59
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 0.58
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 0.58
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.57
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 0.57
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.56
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.56
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.56
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 0.55
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.54
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.54
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.54
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 0.53
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.53
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.53
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.52
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 0.51
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 0.51
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.51
The Glioma-Infiltrating T Cell Receptor Repertoire 0.5
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 0.49
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.47
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.47
Measure transcript integrity using RNA-seq data 0.46
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.45
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 0.45
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 0.44
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.42
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 0.42
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.41
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.41
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.41
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 0.41
O-glcnAc reprograms cellular energetics 0.4
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.4
Single-cell analysis of adult human ovary using 10X genomics 0.39
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.39
Interphase condensins regulate ligand-depedent enhancer activation 0.39
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.38
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.38
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.37
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.36
Identification of global XBP1s target gene expression in human prostate cancer cells 0.36
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 0.36
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.35
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.35
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.34
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.33
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.33
FOXP1 orchestration of ASD-relevant signaling pathways. 0.32
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.32
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.32
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.31
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.3
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.3
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.29
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.29
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.28
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.28
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.28
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.28
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.26
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.26
RNA-Seq and expression data from human adipose tissue 0.26
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.26
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 0.25
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 0.23
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.23
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.22
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.22
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.22
RNA editing in nascent RNA affects pre-mRNA splicing 0.21
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.2
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.2
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.19
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.18
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.17
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 0.16
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 0.16
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.16
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.16
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.15
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.14
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.14
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.14
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.14
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.14
Genome-wide analysis of the Integrator complex (HTS) 0.12
Genome-wide analysis of the Integrator complex 0.12
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 0.12
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.12
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.11
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.11
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.11
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.11
The Genetic Landscape of Diamond-Blackfan Anemia 0.1
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.1
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.08
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.08
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.07
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.07
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 0.06
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.06
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 0.04
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 0.04
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.04
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.04
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 0.04
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.03
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 0.02
The cohesin complex prevents Myc-induced replication stress 0.02
N6-methyladenine DNA Modification in Glioblastoma 0.02
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.02
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.01
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.01
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.01
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.0
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.0
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.0
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation